Evidence map›Paper›PMID 28091565›Full record

ArticleScientific reports2017

Shi Qi, Yang Zhongyi, Zhang Yingjian, Hu Chaosu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Biodistribution Assessment of a NovelLife (Basel, Switzerland) · 2024
    Article
  3. PretreatmentCancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
  4. Predictive value ofFrontiers in immunology · 2023
    Article
  5. Article
  6. Glucose-Thymidine Ratio as a Metabolism Index UsingInternational journal of molecular sciences · 2022
    Article
  7. M1 stage subdivisions based onTherapeutic advances in medical oncology · 2022
    Article
  8. Review
  9. Article
  10. Predictive value of 3'-deoxy-3'-Journal for immunotherapy of cancer · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Value of early evaluation of treatment response usingEuropean journal of nuclear medicine and molecular imaging · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Shi QiDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yang ZhongyiDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Center for Biomedical Imaging, Fudan University; Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai 200032, China.
Zhang YingjianDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; Center for Biomedical Imaging, Fudan University; Shanghai Engineering Research Center for Molecular Imaging Probes, Shanghai 200032, China.
Hu ChaosuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Fudan University Shanghai Cancer Center · CNFudan University · CNLaboratoire d’Imagerie Biomédicale · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to explore the feasibility of

Indexed as

ChemoradiotherapyPositron Emission Tomography Computed TomographyAdultCarcinomaDideoxynucleosidesFemaleFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPredictive Value of TestsRemission InductionTreatment OutcomealovudineDideoxynucleosidesFluorodeoxyglucose F18

Identifiers

PMID28091565
PMCPMC5238364
OpenAlexW2572176334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.